NCT03949075View on ClinicalTrials.gov

Impact of Angiotensin Converting Enzyme Activity on Exercise Training Sensitivity

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

May 15, 2019

Primary Completion Date

December 30, 2019

Study Completion Date

December 30, 2019

Conditions
ExerciseAngiotensin-Converting Enzyme Inhibitors
Interventions
DRUG

Enalapril

Participants will be assigned to daily administration of ACE inhibitors (Initially 5 mg Corodil® 'Enalapril' daily followed by up to 20 mg daily dependent on the blood pressure response) combined with an 8-week training period.

DRUG

Placebo

Participants will be assigned to daily administration of placebo (5-20 mg CaCO3) combined with an 8-week training period.

Trial Locations (1)

2100

Department of Nutrition, Exercise and Sports, Copenhagen

All Listed Sponsors
lead

University of Copenhagen

OTHER

NCT03949075 - Impact of Angiotensin Converting Enzyme Activity on Exercise Training Sensitivity | Biotech Hunter | Biotech Hunter